Native Aortic Valve Infective Endocarditis Secondary to Community-Acquired Methicillin-Resistant Staphylococcus

Saif Awlad Thani1, Shahd M Al Jamei2, Kadhiya N Al Azri2

  • 1Pediatric Critical Care, The Royal Hospital, Muscat, OMN.

Cureus
|April 1, 2024
PubMed

Insights

This case report details a rare instance of methicillin-resistant Staphylococcus aureus (MRSA) infective endocarditis in an infant. Despite prompt intervention, the infection led to severe complications and a fatal outcome, highlighting treatment challenges.

Area of Science:

  • Pediatric Cardiology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Infective endocarditis (IE) is a serious microbial infection of the heart's inner lining or valves.
  • Native aortic valve endocarditis in children is uncommon and carries risks of significant complications.
  • Community-acquired methicillin-resistant Staphylococcus aureus (MRSA) IE in pediatric patients is exceptionally rare.

Observation:

  • A previously healthy seven-month-old infant presented with shock and systemic emboli.
  • Blood cultures confirmed MRSA as the causative agent of native aortic valve IE.
  • The infant developed severe aortic valve insufficiency, heart failure, and multiorgan septic emboli.

Findings:

  • The infant's condition rapidly deteriorated despite management.
  • Refractory multiorgan failure ensued, leading to a fatal outcome.
  • This case underscores the aggressive nature and poor prognosis of MRSA native aortic valve endocarditis in infants.

Implications:

  • Management of complicated pediatric aortic valve endocarditis is complex.
  • A multidisciplinary team approach is crucial for optimal patient outcomes.
  • Early diagnosis and prompt, aggressive intervention are vital in pediatric IE cases.